Tenax Therapeutics
(TENX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 04-2005 | 04-2004 | 04-2003 | 04-2002 | 04-2001 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 589 | 302 | 178 | 2,442 | 4,251 |
| Other current assets | 0 | 0 | 0 | 0 | 30 |
| TOTAL | $666 | $421 | $251 | $2,532 | $4,364 |
| Non-Current Assets | |||||
| PPE Net | 384 | 407 | 426 | 486 | 244 |
| Intangibles | 212 | 220 | 238 | 259 | 234 |
| TOTAL | $596 | $627 | $664 | $744 | $478 |
| Total Assets | $1,262 | $1,048 | $915 | $3,276 | $4,842 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 270 | 237 | 12 | 41 | 87 |
| Accrued Expenses | 44 | 56 | 2 | 32 | 80 |
| TOTAL | $314 | $294 | $15 | $179 | $344 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $314 | $294 | $15 | $179 | $344 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | N/A | N/A | N/A | N/A | 14 |
| Common Shares | 1,257 | 1,138 | 888 | 886 | 845 |
| Retained earnings | -23,623 | -20,950 | -18,701 | -16,473 | -12,986 |
| Other shareholders' equity | 31 | -143 | 0 | 0 | 94 |
| TOTAL | $948 | $754 | $900 | $3,097 | $4,498 |
| Total Liabilities And Equity | $1,262 | $1,048 | $915 | $3,276 | $4,842 |